Abstract:The synthesis of a range of 3-hydroxy-4(1H)-pyridinones with potential for the chelation of iron(III) is described. The pK(a) values of respective ligands and the stability constants of their iron(III) complexes are presented, The distribution coefficient values of a range of 48 hydroxypyridinones and their corresponding iron(III) complexes between l-octanol and MOPS buffer (pH 7.4) are reported. The range of log D-complex values covers 7 orders of magnitude. The results suggest the existence of a biphasic relationship between the distribution coefficient values of the chelator and the corresponding iron(III) complexes. For ligands with a log D-ligand = -1, a linear relationship exists with a value of the slope 2.53, whereas with ligands with a log D-ligand < -1, a linear relationship exists with a slope of 0.49. The reduced slope for the more hydrophilic molecules of the series offers some advantage for this type of hydroxypyridinone as the distribution coefficients for such complexes do not change so rapidly with increasing ligand hydrophilicity. The ability of selected 3-hydroxypyridinones to facilitate the excretion of iron in bile was investigated in non-iron-overloaded, bile duct-cannulated rats and in a [Fe-59]ferritin-loaded rat model. Both systems compare the ability of chelators to remove iron from the liver, the prime target organ in thalassemia. The N-(hydroxyalkyl)-3-hydroxypyridin-4-ones are demonstrated to be orally active under the in vivo conditions adopted. Thus both 1-(hydroxyalkyl)- and 1-(carboxyalkyl)pyridinones are able to remove iron from the liver. Although 1-(carboxyalkyl)hydroxypyridinones are active, they do not demonstrate any clear advantage over Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one). Indeed 1-(hydroxyalkyl)hydroxypyridinones which are known to be rapidly converted to 1-(carboxyalkyl)hydroxypyridinones are also marginally superior to Deferiprone. In contrast, 2-ethyl-1-(2'-hydroxyethyl)-3-hyaroxypyridin-4-one, which is not metabolized to the corresponding (carboxyalkyl)hydroxypyridinone, was found to be superior to Deferiprone and therefore deserves further consideration as an orally active iron chelator with potential for the treatment of iron overload associated with transfusion-dependent thalassemia.

Synthesis of deferasirox, an iron chelator

Investigation on the synthesis of 25-hydroxycholesterol.

Synthesis and Biological Evaluation of Deferiprone-Resveratrol Hybrids As Antioxidants, Aβ1–42 Aggregation Inhibitors and Metal-Chelating Agents for Alzheimer's Disease

Synthesis of (+)-2R,2'S-thiodisuccinic acid with L-aspartate as a chiral pool

Deferasirox-TAT(47–57) peptide conjugate as a water soluble, bifunctional iron chelator with potential use in neuromedicine

Design of a water-soluble chitosan-based polymer with antioxidant and chelating properties for labile iron extraction

Synthesis, Physicochemical Properties, and Evaluation of<i>N</i>-Substituted-2-alkyl-3-hydroxy-4(1<i>H</i>)-pyridinones<sup>†</sup>

In vitro studies of deferasirox derivatives as potential organelle-targeting traceable anti-cancer therapeutics

New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis

A Water-Soluble Chitosan Derivative for the Release of Bioactive Deferoxamine

Synthesis of a New Antihyperlipidaemic Agent-Simvastatin

CN128: A New Orally Active Hydroxypyridinone Iron Chelator.

Design and Synthesis of Novel Pegylated Iron Chelators with Decreased Metabolic Rate

Design, synthesis and evaluation of novel deferasirox derivatives with high antifungal potency in vitro and in vivo

Multicomponent Dearomative Difluoroalkylation of Isoquinolines with Difluorinated Silyl Enol Ethers: Divergent Synthesis of Gem-Difluorinated Heterocycles.

A Mild and Modular Approach to the Total Synthesis of Desferrioxamine B

Visible-Light-Driven Iron-Catalyzed 1,2-Difluoroalkylthiolation of Alkenes

Flow of vapour in a liquid enclosure

ATH434, a promising iron-targeting compound for treating iron regulation disorders

An Improved Process for Chiron Synthesis of the Atorvastatin Side Chain

Photoredox Metal-Free Allylic Defluorinative Silylation of α‐Trifluoromethylstyrenes with Hydrosilanes